Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Aridis Pharma Says Phase 2a Study Of AR-501 In Cystic Fibrosis Meets Endpoints

Por: RTTNews Health March 13, 2023

thumbnail

Aridis Pharmaceuticals, Inc. () announced Monday preliminary top-line results from the randomized, double blinded, placebo-controlled Phase 2a study of AR-501, which evaluated the safety and pharmacokinetics of three ascending doses of AR-501 administered as an inhaled aerosol in cystic fibrosis (CF) patients with confirmed Pseudomonas aeruginosa bacterial and other potential infections.The study was conducted with funding support from the... + full article



Similar News

Cystic fibrosis will no longer automatically qualify for Make-A-Wish

WPTV USA Nation March 16, 2023

thumbnailStarting in 2024, individuals with cystic fibrosis will no longer automatically qualify to receive a wish from the Make-A-Wish Foundation.The nonprofit organization grants wishes to children who have been diagnosed with critical illnesses or conditions that jeopardize their... + más

‘Miracle’ Cystic Fibrosis Drug Kept Out of Reach in Developing Countries | The New York Times

Indiana dad raffling off more of prized bourbon collection to find a cure for his son | 10 WBNS


MGB-backed biotech raises $85m to develop drugs for diseases that cause scarring in organs

The Boston Globe USA Business March 15, 2023

thumbnailA small Cambridge biotech said Wednesday it has raised $85 million in fresh venture capital and appointed a pharmaceutical industry veteran chief executive as the startup works on potential treatments for fibrosis, the often deadly scarring of organs caused by a variety... + más

MGB commits to multimillion dollar cost-cutting plan. Here’s what happens next | The Boston Globe

US health system will go 'bankrupt' in 'a few years,' biotech entrepreneur warns | Fox Business


‘Miracle’ Cystic Fibrosis Drug Kept Out of Reach in Developing Countries

The New York Times USA Health February 08, 2023

thumbnailWhen Seshagiri Buddana learned of a powerful new cystic fibrosis drug that was transforming lives in the United States and Europe, he was filled with hope that it could help his son, Hemanth, who had spent much of his childhood in a hospital bed. But the family couldn’t get... + más

Indiana dad raffling off more of prized bourbon collection to find a cure for his son | 10 WBNS

Lessons From a ‘Difficult Patient’ | The New York Times


4-year-old Louisiana girl with Cystic Fibrosis receives new lungs

10 WBNS USA Health December 05, 2022

thumbnailCOVINGTON, La. — Doctors, nurses, and other members of the medical team clapped and waved at 4-year-old Ava Thomas last Monday as she was rolled down the hospital hallway. She's waited a long time and at that moment she knew she was getting her new lungs, John Thomas,... + más

Indiana dad raffling off more of prized bourbon collection to find a cure for his son | 10 WBNS

Lessons From a ‘Difficult Patient’ | The New York Times


Lessons From a ‘Difficult Patient’

The New York Times USA Health October 18, 2022

thumbnailSal was 58 when I was assigned his case. Sal had been diagnosed with cystic fibrosis in the 1960s and was considered an old survivor; all his friends who had been diagnosed at the same time, including his younger brother, were dead.I was 21, a few weeks out of college and one of... + más

Man plays saxophone through brain surgery to remove tumor | 10 WBNS

The technology, devices, and benefits of remote patient monitoring in the healthcare industry | Business Insider


Indiana dad raffling off more of prized bourbon collection to find a cure for his son

10 WBNS USA Health October 06, 2022

thumbnailLOUISVILLE, Ky. — A father in Carmel is continuing his mission to prolong his 3-year-old son's life by to raise money for the Cystic Fibrosis Foundation. 's life includes a devastating genetic disorder. Doctors diagnosed him with cystic fibrosis through a blood... + más

Neat to sweet, Orlando craft cocktail pros celebrate Bourbon Heritage Month | Orlando Sentinel

Kentucky Bourbon Trail on pace to surpass record-high number of distillery visitations in a year | Fox Business


Eloxx Pharma Shares Plummet As Class 1 Cystic Fibrosis Trial Fails

RTTNews USA Health September 24, 2022

thumbnailShares of Eloxx Pharmaceuticals, Inc. () are down over 42% at $0.22 in premarket trading session on Thursday, following disappointing results from the company's phase II combination trial of ELX-02 in Class 1 cystic fibrosis patients.The phase II combination clinical trial... + más

Indiana dad raffling off more of prized bourbon collection to find a cure for his son | 10 WBNS

Council Post: How Social Media Analytics Is Transforming Pharma Decision Making | Forbes



About iurex | Privacy Policy | Disclaimer |